Literature DB >> 29970604

Nuclear import pathway key to rescuing dominant progerin phenotypes.

Katherine L Wilson1.   

Abstract

In this issue of Science Signaling, Larrieu et al show that an acetyltransferase inhibitor that rescues many dominant nuclear phenotypes caused by progerin, a truncated form of lamin A, does so by releasing the specialized nuclear import receptor TNPO1 from sequestration by microtubules. This release enables TNPO1-dependent import of specific cargoes, including the nuclear pore protein Nup153 and the heterogeneous nuclear ribonucleoprotein hnRNPA1, thus restoring the functionality of nuclear pore complexes, rebalancing the nucleocytoplasmic Ran gradient, and normalizing gene expression.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29970604      PMCID: PMC6504936          DOI: 10.1126/scisignal.aat9448

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  10 in total

1.  Molecular characterization of the Ran-binding zinc finger domain of Nup153.

Authors:  Meda M Higa; Steven L Alam; Wesley I Sundquist; Katharine S Ullman
Journal:  J Biol Chem       Date:  2007-04-10       Impact factor: 5.157

Review 2.  Nuclear Pore Protein Meets Transcription Factor in Neural Fate.

Authors:  Taro Kitazawa; Filippo M Rijli
Journal:  Neuron       Date:  2017-10-11       Impact factor: 17.173

3.  Protein Tpr is required for establishing nuclear pore-associated zones of heterochromatin exclusion.

Authors:  Sandra Krull; Julia Dörries; Björn Boysen; Sonja Reidenbach; Lars Magnius; Helene Norder; Johan Thyberg; Volker C Cordes
Journal:  EMBO J       Date:  2010-04-20       Impact factor: 11.598

4.  Nup153 Recruits the Nup107-160 Complex to the Inner Nuclear Membrane for Interphasic Nuclear Pore Complex Assembly.

Authors:  Benjamin Vollmer; Michael Lorenz; Daniel Moreno-Andrés; Mona Bodenhöfer; Paola De Magistris; Susanne Adina Astrinidis; Allana Schooley; Matthias Flötenmeyer; Sebastian Leptihn; Wolfram Antonin
Journal:  Dev Cell       Date:  2015-06-04       Impact factor: 12.270

5.  Inhibition of the acetyltransferase NAT10 normalizes progeric and aging cells by rebalancing the Transportin-1 nuclear import pathway.

Authors:  Delphine Larrieu; Emmanuelle Viré; Samuel Robson; Sophia Y Breusegem; Tony Kouzarides; Stephen P Jackson
Journal:  Sci Signal       Date:  2018-07-03       Impact factor: 8.192

6.  Chemical inhibition of NAT10 corrects defects of laminopathic cells.

Authors:  Delphine Larrieu; Sébastien Britton; Mukerrem Demir; Raphaël Rodriguez; Stephen P Jackson
Journal:  Science       Date:  2014-05-02       Impact factor: 47.728

7.  A ternary complex comprising transportin1, Rab8 and the ciliary targeting signal directs proteins to ciliary membranes.

Authors:  Viswanadh Madugula; Lei Lu
Journal:  J Cell Sci       Date:  2016-09-15       Impact factor: 5.285

8.  Defective nuclear import of Tpr in Progeria reflects the Ran sensitivity of large cargo transport.

Authors:  Chelsi J Snow; Ashraf Dar; Anindya Dutta; Ralph H Kehlenbach; Bryce M Paschal
Journal:  J Cell Biol       Date:  2013-05-06       Impact factor: 10.539

9.  Prelamin A impairs 53BP1 nuclear entry by mislocalizing NUP153 and disrupting the Ran gradient.

Authors:  Andrew M Cobb; Delphine Larrieu; Derek T Warren; Yiwen Liu; Sonal Srivastava; Andrew J O Smith; Richard P Bowater; Stephen P Jackson; Catherine M Shanahan
Journal:  Aging Cell       Date:  2016-07-27       Impact factor: 9.304

10.  The non-classical nuclear import carrier Transportin 1 modulates circadian rhythms through its effect on PER1 nuclear localization.

Authors:  Sandra Korge; Bert Maier; Franziska Brüning; Lea Ehrhardt; Thomas Korte; Matthias Mann; Andreas Herrmann; Maria S Robles; Achim Kramer
Journal:  PLoS Genet       Date:  2018-01-29       Impact factor: 5.917

  10 in total
  3 in total

Review 1.  Hutchinson-Gilford Progeria Syndrome-Current Status and Prospects for Gene Therapy Treatment.

Authors:  Katarzyna Piekarowicz; Magdalena Machowska; Volha Dzianisava; Ryszard Rzepecki
Journal:  Cells       Date:  2019-01-25       Impact factor: 6.600

2.  Arterial stiffness and cardiac dysfunction in Hutchinson-Gilford Progeria Syndrome corrected by inhibition of lysyl oxidase.

Authors:  Ryan von Kleeck; Emilia Roberts; Paola Castagnino; Kyle Bruun; Sonja A Brankovic; Elizabeth A Hawthorne; Tina Xu; John W Tobias; Richard K Assoian
Journal:  Life Sci Alliance       Date:  2021-03-09

3.  Mutant Presenilin 1 Dysregulates Exosomal Proteome Cargo Produced by Human-Induced Pluripotent Stem Cell Neurons.

Authors:  Sonia Podvin; Alexander Jones; Qing Liu; Brent Aulston; Charles Mosier; Janneca Ames; Charisse Winston; Christopher B Lietz; Zhenze Jiang; Anthony J O'Donoghue; Tsuneya Ikezu; Robert A Rissman; Shauna H Yuan; Vivian Hook
Journal:  ACS Omega       Date:  2021-05-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.